Compounds > glucagon
Page last updated: 2024-09-04

glucagon and carbostyril

glucagon has been researched along with carbostyril in 3 studies

Compound Research Comparison

Studies
(glucagon)		Trials
(glucagon)		Recent Studies (post-2010)
(glucagon)		Studies
(carbostyril)		Trials
(carbostyril)		Recent Studies (post-2010) (carbostyril)
26,0391,4983,05412,8551,3235,611

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benelli, C; Desbuquois, B; Fouque, F; Geoffroy, V; Lugnier, C1
Hernández, J; Juan-Fita, MJ; Vargas, ML1
Bartlett, JB; Berg, S; Carey, F; Charles, AD; Convey, G; De Schoolmeester, J; Freeman, S; Loxham, SJ; Poucher, SM; Teague, J; Turnbull, AV; Walker, M1

Other Studies

3 other study(ies) available for glucagon and carbostyril

ArticleYear
Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
    Archives of biochemistry and biophysics, 2001, Mar-01, Volume: 387, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Endosomes; Gene Expression Regulation, Enzymologic; Glucagon; Golgi Apparatus; Growth Hormone; Hormones; Insulin; Isoenzymes; Liver; Male; Obesity; Phosphodiesterase Inhibitors; Pyridazines; Quinolones; Rats; Rats, Zucker; Subcellular Fractions

2001
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
    European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines

2005
An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.
    British journal of pharmacology, 2007, Volume: 152, Issue:8

    Topics: Animals; Blood Glucose; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucose; Glucose Tolerance Test; Glycogen Phosphorylase; Glycogen Synthase; Hepatocytes; Hyperglycemia; Inhibitory Concentration 50; Male; Obesity; Quinolones; Rats; Rats, Wistar; Rats, Zucker; Thiophenes

2007